Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The case for statins: has it really been made?

Literature DB >> 15459255

The case for statins: has it really been made?

Andrew Thompson, Norman J Temple.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2004 PMID： 15459255 PMCID： PMC1079612 DOI： 10.1177/0141076809701002

Source DB: PubMed Journal: J R Soc Med ISSN： 0141-0768 Impact factor: 18.000

× No keyword cloud information.

16 in total

1. Placebo-controlled trials and the Declaration of Helsinki.

Authors: John A Lewis; Bertil Jonsson; Gottfried Kreutz; Cristina Sampaio; Barbara van Zwieten-Boot
Journal: Lancet Date: 2002-04-13 Impact factor: 79.321

2. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Authors:
Journal: JAMA Date: 2002-12-18 Impact factor: 56.272

3. New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population.

Authors: Donald O Fedder; Carol E Koro; Gilbert J L'Italien
Journal: Circulation Date: 2002-01-15 Impact factor: 29.690

4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors: F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245

5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors:
Journal: Lancet Date: 1994-11-19 Impact factor: 79.321

6. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Authors:
Journal: N Engl J Med Date: 1998-11-05 Impact factor: 91.245

7. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

Authors: S J Lewis; L A Moye; F M Sacks; D E Johnstone; G Timmis; J Mitchell; M Limacher; S Kell; S P Glasser; J Grant; B R Davis; M A Pfeffer; E Braunwald
Journal: Ann Intern Med Date: 1998-11-01 Impact factor: 25.391

8. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.

Authors:
Journal: Eur Heart J Date: 1987-01 Impact factor: 29.983

9. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

Authors:
Journal: Arch Intern Med Date: 1988-01

10. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors: J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal: N Engl J Med Date: 1995-11-16 Impact factor: 91.245

3 in total